JILL KING: Open Payments
NPI 1932987096 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 6 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $515 · 2025 $299
Food & beverage: $212Education: $87
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $111 |
| Lilly USA, LLC | 1 | $87 |
| Astellas Pharma US Inc | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Aveo Pharmaceuticals, Inc. | 1 | $25 |
| Rigel Pharmaceuticals, Inc. | 1 | $16 |
Products named: DATROWAY, Vyloy, LIBTAYO, FOTIVDA, TAVALISSE.
Industry payments across TX — which companies pay providers there.
